ClinicalTrials.gg
DrugBiological

Infliximab clinical trials

Also written Remicade, SCH 215596 and TA-650.

Includes 2 studies of BCD-055 and 2 studies of GP1111.

studies test it
249
open now
33
in phase 3
85
first study started
1995

How each study uses Infliximab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Infliximab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
24 Aug 1998 · REMICADE · BLA 103772 (FDA, Drugs@FDA)
European Union
13 Aug 1999 · Remicade · EMEA/H/C/000240 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Infliximab
182
Remicade, SCH 215596
4
Topical Infliximab
3
IFX
3
Infliximab (Remicade)
3

Brand

Remicade
82

Development codes

SCH 215596
15
TA-650
6
NI-071
3
CMAB008
2
ABP 710
1
BCD-055
1
BOW015
1

Biosimilars

Remsima
9
AVSOLA
3
Renflexis
3
Ixifi
2
Infliximab-abda
1
Zessly
1
Infliximab-Dyyb
1
GB242
1

Studies by the year they started

241 studies that test it; most in 2003 (18)

Studies that test Infliximab, by start year
YearStudies
19951
19962
19971
20001
20014
20028
200318
20045
200514
200614
200718
200811
20099
201010
20115
201214
201312
20146
201510
201611
20177
20184
20194
202010
20219
20228
20237
20244
20257
20267

By phase

A phase 1/2 study counts in both.

Phase 1
23
Phase 2
61
Phase 3
85
Phase 4
75
No phase
21

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 86 · Other 163

Merck Sharp & Dohme LLC (25) · Centocor, Inc. (20) · Tanabe Pharma Corporation (7) · Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (5) · Emory University (5) · Celltrion (5) · Massachusetts General Hospital (4) · National Institute of Allergy and Infectious Diseases (NIAID) (4)

Often tested with

Tested in the same studies.

Adalimumab (18) · Etanercept (13) · Methotrexate (12) · Azathioprine (9) · Golimumab (8) · Certolizumab Pegol (7) · Tocilizumab (6) · Abatacept (5)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8

Studies that test Infliximab.

Studies

Open first, then newest update. How each study uses Infliximab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 249

See all 249 studies that test Infliximab →

Given beside what is tested · 7 — Infliximab is usual care or a partner of the new treatment
As the comparator · 22 — what is tested is compared with Infliximab

Showing 20 of 22.

Codes

What other systems call Infliximab · ClinicalTrials.gg INT006568

  • MeSH (NLM) D000069285InfliximabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) B72HH48FLUINFLIXIMABConfirmed FDA, NLM, Wikidata
  • RxNorm 191831Confirmed FDA, Wikidata
  • Wikidata Q415264infliximabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1789InfliximabOne source FDA
  • DrugBank DB00065One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.